World's Best Scientists 2026 revealed!

Eleonora Fabianova publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Eleonora Fabianova sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

The last bar groups every scientist with 1,796 publications or more.

Eleonora Fabianova D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Eleonora Fabianova sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

The last bar groups every scientist with 217 D-Index or more.

Overview

Eleonora Fabianova is affiliated with the Regional Authority of Public Health in Slovakia and has contributed extensively to the field of medicine, with a focus on infectious diseases, pulmonary and respiratory medicine, health toxicology, mutagenesis, and cancer research.

Their research spans multiple key topics, including:

  • SARS-CoV-2 and COVID-19 research
  • Occupational and environmental lung diseases
  • Air quality and health impacts
  • COVID-19 clinical research studies
  • COVID-19 epidemiological studies
  • Carcinogens and genotoxicity assessment
  • Head and neck cancer studies

Fabianova's work is represented in prominent publication venues, with frequent contributions to:

  • Vaccines
  • Frontiers in Immunology
  • Scandinavian Journal of Work Environment & Health
  • Cancer Epidemiology Biomarkers & Prevention
  • American Journal of Clinical Nutrition

Among Fabianova's recent papers are:

  • Lessons learned from the INHANCE consortium: An overview of recent results on head and neck cancer, 2020, Oral Diseases
  • Occupational Exposure to Polycyclic Aromatic Hydrocarbons and Lung Cancer Risk: Results from a Pooled Analysis of Case-Control Studies (SYNERGY), 2022, Cancer Epidemiology Biomarkers & Prevention
  • Hepcidin-regulating iron metabolism genes and pancreatic ductal adenocarcinoma: a pathway analysis of genome-wide association studies, 2021, American Journal of Clinical Nutrition
  • Determinants of anti-S immune response at 6 months after COVID-19 vaccination in a multicentric European cohort of healthcare workers - ORCHESTRA project, 2022, Frontiers in Immunology
  • Poor oral health influences head and neck cancer patient survival: an International Head and Neck Cancer Epidemiology Consortium pooled analysis, 2023, JNCI Journal of the National Cancer Institute

Frequent co-authors collaborating with Fabianova include:

  • Paolo Boffetta
  • Dana Mateș
  • Guillermo Fernández-Tardón
  • Lorenzo Richiardi
  • Adonina Tardón

Best Publications

  • A susceptibility locus for lung cancer maps to nicotinic acetylcholine receptor subunit genes on 15q25

    Rayjean J. Hung;James D. Mckay;Valerie Gaborieau;Paolo Boffetta

  • Interaction between tobacco and alcohol use and the risk of head and neck cancer: pooled analysis in the International Head and Neck Cancer Epidemiology Consortium.

    Mia Hashibe;Paul Brennan;Shu Chun Chuang;Stefania Boccia

  • An increased micronucleus frequency in peripheral blood lymphocytes predicts the risk of cancer in humans.

    Stefano Bonassi;Ariana Znaor;Marcello Ceppi;Cecilia Lando

  • Genome-wide meta-analyses identify multiple loci associated with smoking behavior

    Helena Furberg;Yunjung Kim;Jennifer Dackor;Eric Boerwinkle

  • Alcohol Drinking in Never Users of Tobacco, Cigarette Smoking in Never Drinkers, and the Risk of Head and Neck Cancer: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Mia Hashibe;Paul Brennan;Simone Benhamou;Xavier Castellsague

  • Lung cancer susceptibility locus at 5p15.33

    James D McKay;Rayjean J Hung;Rayjean J Hung;Valerie Gaborieau;Paolo Boffetta

  • Cigarette smoking and lung cancer – relative risk estimates for the major histological types from a pooled analysis of case-control studies

    Beate Pesch;Benjamin Kendzia;Per Gustavsson;Karl Heinz Jöckel

  • High prevalence of mutant KRAS in circulating exosome-derived DNA from early-stage pancreatic cancer patients.

    K. Allenson;J. Castillo;F. A. San Lucas;G. Scelo

  • Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer

    Yufei Wang;James D McKay;Thorunn Rafnar;Zhaoming Wang

  • Chromosomal aberration frequency in lymphocytes predicts the risk of cancer: results from a pooled cohort study of 22 358 subjects in 11 countries

    Stefano Bonassi;Hannu Norppa;Marcello Ceppi;Ulf Strömberg

  • Chromosomal aberrations and SCEs as biomarkers of cancer risk

    H. Norppa;S. Bonassi;I-L. Hansteen;L. Hagmar

  • Cessation of alcohol drinking, tobacco smoking and the reversal of head and neck cancer risk

    Manuela Marron;Manuela Marron;Paolo Boffetta;Zuo Feng Zhang;David Zaridze

  • Cigarette, Cigar, and Pipe Smoking and the Risk of Head and Neck Cancers: Pooled Analysis in the International Head and Neck Cancer Epidemiology Consortium

    Annah Wyss;Mia Hashibe;Shu Chun Chuang;Yuan Chin Amy Lee

  • A Genome-Wide Association Study of Upper Aerodigestive Tract Cancers Conducted within the INHANCE Consortium

    James D. McKay;Therese Truong;Valerie Gaborieau;Amelie Chabrier

  • Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3

    Mark P. Purdue;Mattias Johansson;Diana Zelenika;Jorge R. Toro

  • Diabetes, antidiabetic medications and pancreatic cancer risk: an analysis from the international pancreatic cancer case-control consortium

    C. Bosetti;V. Rosato;D. Li;D. Silverman

  • Adult height and head and neck cancer: A pooled analysis within the INHANCE Consortium

    E. Leoncini;W. Ricciardi;G. Cadoni;D. Arzani

  • Influence of common genetic variation on lung cancer risk: meta-analysis of 14 900 cases and 29 485 controls

    Maria N. Timofeeva;Rayjean J. Hung;Thorunn Rafnar;David C. Christiani

  • Total Exposure and Exposure Rate Effects for Alcohol and Smoking and Risk of Head and Neck Cancer: A Pooled Analysis of Case-Control Studies

    Jay H. Lubin;Mark Purdue;Karl Kelsey;Zuo Feng Zhang

  • Previous Lung Diseases and Lung Cancer Risk: A Pooled Analysis From the International Lung Cancer Consortium

    Darren R. Brenner;Paolo Boffetta;Eric J. Duell;Heike Bickeböller

Frequent Co-Authors

Paolo Boffetta
Paolo Boffetta Stony Brook Medicine
Peter Rudnai
Peter Rudnai National Institutes of Health
Jolanta Lissowska
Jolanta Lissowska Maria Sklodowska-Curie National Research Institute of Oncology
Paul Brennan
Paul Brennan International Agency For Research On Cancer
Lenka Foretova
Lenka Foretova Masaryk University
David Zaridze
David Zaridze Russian Cancer Research Center NN Blokhin
Rayjean J. Hung
Rayjean J. Hung Lunenfeld-Tanenbaum Research Institute
James McKay
James McKay International Agency For Research On Cancer
Mia Hashibe
Mia Hashibe University of Utah

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Considering a future in medicine extends beyond traditional MD programs. Many students are exploring alternative healthcare careers and online education options that offer both flexibility and strong career prospects.

For those drawn to nursing leadership roles, pursuing one of the best DNP programs online can open doors to advanced practice and executive positions. Pharmacists are also in high demand, and enrolling in the best online pharmacy school programs provides a streamlined path to this rewarding field.

Not all healthcare careers require years of medical school. Earning an HIM associate degree online prepares graduates for roles managing crucial health data and patient records. Meanwhile, those seeking quick entry into healthcare support roles might consider the cheapest medical billing and coding online courses.

Each of these accredited programs can offer a flexible, affordable pathway to a fulfilling healthcare career, whether your interests are clinical or administrative.

Best Scientists Citing Eleonora Fabianova

Trending Scientists

Recently Published Articles